European stroke initiative: Recommendations for stroke management: Organisation of stroke care

Journal of Neurology

Volumn 247, Issue 9, 2000, Pages 732-748

  Hacke, W ^a   Kaste, M ^a   Olsen, T S ^a   Orgogozo, J M ^a   Bogousslavsky, J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acute stroke treatment; Guideline; Stroke; Stroke prevention; Stroke units

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANCROD; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BARBITURIC ACID DERIVATIVE; CAPTOPRIL; CLONIDINE; CORTICOSTEROID; DIHYDRALAZINE; DIURETIC AGENT; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; INOTROPIC AGENT; LABETALOL; METOPROLOL; NIFEDIPINE; NITROPRUSSIDE SODIUM; NORADRENALIN; OXYGEN; PARACETAMOL; PROUROKINASE; STREPTOKINASE; TROMETAMOL; UNINDEXED DRUG; URAPIDIL; UROKINASE;

ACUTE DISEASE; ANTICOAGULANT THERAPY; ARTERY SURGERY; ARTICLE; BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC TEST; EARLY DIAGNOSIS; EDUCATION PROGRAM; EMERGENCY TREATMENT; EUROPE; FIBRINOLYTIC THERAPY; FUNCTIONAL ASSESSMENT; HUMAN; INFECTION COMPLICATION; INTENSIVE CARE; MEDICAL SOCIETY; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; STROKE; THROMBOSIS PREVENTION;

ACUTE DISEASE; CEREBROVASCULAR ACCIDENT; DIAGNOSIS, DIFFERENTIAL; EMERGENCY SERVICE, HOSPITAL; HUMAN; PATIENT CARE PLANNING; PRACTICE GUIDELINES; PREVENTIVE MEDICINE;

EID: 0033776371     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. Risk of stroke in male cigarette smokers
2. Stroke management in Europe
3. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
4. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
5. Costs and gains in stroke prevention: European perspective
6. Benefit of endarterectomy in patients with symptomatic moderate or severe stenosis
7. Guidelines for carotid endarterectomy statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
8. Stroke, statins and cholesterol: A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors
9. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation
10. Neurological acute stroke care: The role of European neurology
11. Thrombolytic therapy of acute basilar artery occlusion: Variables affecting recanalization and outcome
12. Intensive care for acute stroke in the community hospital setting
13. General therapy of acute ischemic stroke
14. Optimal oral anticoagulation therapy in patients with mechanical heart valves
15. A randomised, blinded trial of dopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
16. Timing for fever-related brain damage in acute ischemic stroke
17. Heparin in stroke with atrial fibrillation
18. Randomized placebo-controlled of early aspirin use in 20:000 patients with acute ischaemic stroke
19. Cigarette smoking and risk of stroke in middle-aged woman
20. Blood pressure, stroke, and coronary heart disease. II. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
21. Canadian Atrial Fibrilation Anticoagulation (CAFA) study
22. European stroke prevention study 2, dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
23. Plasma atrial natriuretic factor and subarchnoid hemorrhage
24. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group
25. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or a minor ischemic stroke
26. Behandlung des akuten ischamischen Insults
27. European strategies for early intervention in stroke
28. Optimal oral anticoagulation therapy with nonrheumatic atrial fibrillation and recent cerebral ischemia
29. MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70-99 %) or with mild (0-29 %) carotid stenosis
30. Neurological acute stroke care: The role of European neurology
31. Endarterectomy for asymptomatic carotid artery stenosis
32. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
33. Guidelines for the management of transient ischemic attacks. From the Ad Hoc committee on guidelines for the management of transient ischemic attacks of the American Heart Association
34. Cost of stroke
35. PROACT II: Recombinant prourokinase (r-ProUK) in Acute Cerebral Thromboembolism. Initial trial results
36. Prevention of first stroke. A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association
37. Recent infection as a risk factor for cerebrovascular ischemia
38. Elective intubation for neurologic deterioration after stroke
39. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease
40. Critical care of acute ischemic stroke
41. 'Malignant' middle cerebral artery territory infarction: Clinical course and prognostic signs
42. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
43. Prevention of stroke in patients with nonvalvular atrial fibrillation: Views and reviews
44. Hypervolemic hemodilution treatment of acute stroke. Results of a randomized multicenter trial using pentastarch
45. Surgical treatment of cerebrellar infarction
46. Aspiration following stroke: Clinical correlates and outcome
47. Stroke unit treatment: Long-term effects
48. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke
49. The cost of stroke to the National Health Service in Scottland
50. Haemodilution in acute stroke: Results of the Italian haemodilution trial
51. Heart type creatine kinase isoenzyme (CK MB) in acute cerebral disorders
52. Early stroke recognition: Developing an out-of-hospital NIH stroke scale
53. Acute stroke: Usefulness of early CT findings before thrombolytic therapy
54. Stroke units: An evidence based approach
55. Antithrombotic therapy in atrial fibrillation
56. Exercise and risk of stroke in male physicians
57. A prospective study of aspirin use and primary prevention of cardiovascular disease in women
58. Thrombolytic therapy with streptokinase in acute ischaemic stroke
59. Tissue plasminogen activator for acute ischemic stroke
60. Effects of cerebrovascular lesions on the heart
61. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis
62. Placebo-controlled, randomised trial warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The AFASAK study
63. Randomised trial of prophylactic daily aspirin in British male doctors
64. Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study
65. Cholesterol, diastolic blood pressure and stroke. 13:000 Strokes in 450:000 people in 45 prospective cohorts
66. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus
67. Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality and outcome
68. Therapeutic strategies in space-occupying cerebellar infarction based on clinical, neuroradiological and neurophysiological data
69. Decompressive surgery in space-occupying hemispheric infarction: Results of an open, prospective trial
70. Hypertension in patients with cerebrovascular accident. To treat or not to treat?
71. Stroke units versus general medical wards. I. Twelve and eighteen-month survival. A randomized, controlled trial
72. The protective effect of moderate alcohol consumption on ischemic stroke
73. Middle cerebral artery occlusion: Correlation of computed tomography and angiography with clinical outcome
74. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events
75. Multicenter trial of hemodilution in acute ischemic stroke: Results in the total patient population
76. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction
77. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)
78. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
79. Defibrinogenation with Viprinex (Ancrod) for the treatment of acute, ischemic stroke
80. Final report of the ongoing physicians health study
81. Prognosis of stroke patients requiring mechanical ventilation in a neurological critical care unit
82. Evaluation of long-term outcome and safety after hemodilution therapy in acute ischemic stroke
83. Stroke Prevention in Atrial Fibrillation: Final results
84. A systematic review of the randomised trials of organised impatient (stroke unit) care after stroke
85. Intravenous heparin for acute stroke. What can we learn from the megatrials?
86. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk complications in patients with type 2 diabetes (UKPDS 33)
87. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Final results
88. Thrombolytic therapy for acute ischaemic stroke - The updated cochrane database of systematic reviews meta-analysis
89. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and Other Cerebrovascular Disorders
90. Angioplasty and stenting for restenosis after carotid endarterectomy, initial experience
91. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcome Prevention Evaluation Study Investigators